Project Grant HT94252310590
Award Date
7/1/23
Completion Date
6/30/27
Dollars Obligated
$3.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Syracuse, NY 13210, USA
Similar Awards
The Department of the Army Medical Command awarded a $1,463,982 Project Grant to The Research Foundation for the State University of New York (RF SUNY) under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project titled "Defining the ABI1-Mediated Resistance to Enzalutamide" to investigate new treatments for military health priorities. The Research Foundation for the State University of New York, which serves as the fiscal...
This $998,436 Project Grant was awarded on July 1, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Research Foundation for the State University of New York (RF SUNY) to study the molecular mechanisms and therapeutic potential of heparan sulfate proteoglycans in remyelination. This 3-year research project aims to transform health care for Service Members and the American public through innovative and...
The U.S. Department of the Army Medical Command awarded a $2,013,978.00 Project Grant to New York University (NYU) School of Medicine on July 1, 2025 under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funds research aimed at "Targeting RAGE After Particulate Matter Exposure: Metabolic Dysregulation and Disease Mitigation" over a performance period ending on June 30, 2028. As a leading academic medical center, NYU School of Medicine will...
This federal Project Grant award of $554,875.00 was awarded on March 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Research Foundation for the State University of New York (RF SUNY). The funding will support a 3-year research project titled "TRANSLATION DYSREGULATION IN METASTATIC BREAST CANCER: IMPLICATIONS FOR DISEASE AND IMMUNOTHERAPY OUTCOMES". The objective is to investigate the role of translational...
This federal Project Grant award of $673,448.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award was granted to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,179,730 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) at the University at Albany. The grant, under the Military Medical Research and Development program (CFDA 12.420), will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder affecting muscle function. The four-year grant, which began on April 1, 2024, will support basic,...
The Defense Health Agency awarded Syracuse University a $1,099,513 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop antimicrobial shape memory polymer foams for rapid hemorrhage control and infection prevention in traumatic wounds. The grant period runs from August 15, 2023 to August 14, 2026. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research focused on...
The federal Project Grant award of $680,757.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research by New York University School of Medicine to investigate the impact of particulate matter exposure on metabolic dysregulation and disease mitigation. The award, effective July 1, 2025 through June 30, 2028, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,938,711 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) on April 1, 2024. The grant will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder that causes progressive muscle weakness and wasting. The project aims to transform health care for service members and the public by conducting...
The Trustees of Columbia University in the City of New York received a $1.9 million Project Grant award from the Department of the Army Medical Command on August 15, 2022 to fund research on Protein Transduction Therapy for Acute Respiratory Distress Syndrome (ARDS). The research will be conducted through August 14, 2025 in New York, NY under the Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and advanced biomedical research with the...